Govinda Bhisetti MSc, PhD

Govinda Bhisetti is a Vice President and Head of Computational Chemistry at Cellarity. He got his Ph. D. from the Indian Institute of Science, Bangalore in 1986. He joined Scripps Research Institute, La Jolla, CA as a postdoctoral fellow in 1987. His work at Scripps involved the use of a Cray XMP supercomputer to simulate protein-ligand interactions and design novel inhibitors. From there, he went to work at Vertex Pharmaceuticals Inc. in 1990 and worked in the Computational Sciences department for 22+ years where he led molecular modeling and drug design efforts on several drug discovery projects. 

His research at Vertex led to the discovery of three FDA-approved drugs: two AIDS drugs, Agenerase (amprenavir) and Lexiva (fosamprenavir), and one Hepatitis C drug, Incivek (Telaprevir). He is a co-inventor of these drugs and named inventor on 26 patents. He published 72 research papers including review articles and book chapters.